English
IRIS BIOTECHNOLOGIES INC
EDGAR37 filing records in this dataset, filed from 2008-03-31 to 2016-11-15. Explore the available filing history and original sources.
- Cash and cash equivalents
- 78.8 thousand USD Source
Exact value
78779 USD
- Long-term debt including current maturities
- 53 thousand USD Source
Exact value
53000 USD
- Shares outstanding
- Not available
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2016-11-15.
Financial data available through: 2010-12-31.
Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.
Coverage by financial measure
- revenue: No compatible figures in this window
- operating income: No compatible figures in this window
- Net income: 4 of 11 periods available· newest 2010-12-31
- Operating cash flow: 4 of 11 periods available· newest 2010-12-31
- Capital expenditure: 4 of 11 periods available· newest 2010-12-31
- Total assets: 4 of 11 periods available· newest 2010-12-31
- Total liabilities: 2 of 11 periods available· newest 2010-12-31
- Current assets: 4 of 11 periods available· newest 2010-12-31
- Current liabilities: 4 of 11 periods available· newest 2010-12-31
- Cash and cash equivalents: 4 of 11 periods available· newest 2010-12-31
- Long-term debt including current maturities: 1 of 11 periods available· newest 2009-12-31
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Net income
+USD 12,594Prior period
−USD 1.09 million
–
Current period
−USD 1.08 million
–
Exact inputs and evidence
-1082047 − -1094641 = 12594 USD
-1094641 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source-1082047 USD · 2010-01-01 – 2010-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 15,104Prior period
−USD 146,722
–
Current period
−USD 161,826
–
Exact inputs and evidence
-161826 − -146722 = -15104 USD
-146722 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source-161826 USD · 2010-01-01 – 2010-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-100%Prior period
USD 6,976
–
Current period
USD 0
–
Exact inputs and evidence
0 − 6976 = -6976 USD
6976 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source0 USD · 2010-01-01 – 2010-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Revenue.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
Revenue is not reported for this company, so its costs cannot be shown as a share of it.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Revenue growth
Change in revenue from the same financial period one year earlier.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|
Operating cash flow
Cash generated by the company’s normal business operations.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Current assets to current liabilities
Current assets divided by current liabilities.
Values and sources
| Period | Series | Value | Source evidence |
|---|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2007 2007-01-01 – 2007-12-31 | −USD 396,953 Exact valueExact value: -396953 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 371,509 Exact valueExact value: -371509 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 41,541 Exact valueExact value: 41541 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 413,050 Calculation and evidence-371509 − 41541 USD Exact free cash flow: -413050 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2008 2008-01-01 – 2008-12-31 | −USD 883,530 Exact valueExact value: -883530 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 696,027 Exact valueExact value: -696027 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 19,226 Exact valueExact value: 19226 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 715,253 Calculation and evidence-696027 − 19226 USD Exact free cash flow: -715253 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2009 2009-01-01 – 2009-12-31 | −USD 1.09 million Exact valueExact value: -1094641 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 146,722 Exact valueExact value: -146722 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 6,976 Exact valueExact value: 6976 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 153,698 Calculation and evidence-146722 − 6976 USD Exact free cash flow: -153698 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2010 2010-01-01 – 2010-12-31 | −USD 1.08 million Exact valueExact value: -1082047 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 161,826 Exact valueExact value: -161826 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 161,826 Calculation and evidence-161826 − 0 USD Exact free cash flow: -161826 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
37 filings · 0 latest values · 0 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0001396238, 1396238, edgar:1396238